drugset / Trial / NCT01480336

The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot

NCT01480336

RandomizedParallel-groupDouble-blind

Summary

The purpose of this study is to learn if combination therapy with amiodarone and ranolazine (an approved drug for chest pain) can help prevent arrhythmias.

Timeline

Start
2011-02
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ranolazine Small molecule 500 mg Oral
Comparator Amiodarone Small molecule